Dutch Parkinson, Cognition and Driving Ability study (DUPARC-drive): An explorative study on driving simulator performance in de novo Parkinson’s Disease patients
- Conditions
- Parkinson's disease
- Registration Number
- NL-OMON20215
- Lead Sponsor
- niversity Medical Center Groningen
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 60
All subjects:
-Dutch speaking
-In possession of a driver’s license
-Active drivers, i.e., having driven at least 300 kilometres in the last year
-Age 18 to 75
-Willingness to cooperate and sign written informed consent
De novo PD subjects:
-Diagnosis Parkinson’s disease, as confirmed by a neurologist specialized in Parkinson’s Disease, by the UK-Brain Bank Criteria.
-Disease duration < 3 months, measured after time of diagnosis.
All subjects:
-Suffering from severe motion sickness; motion sickness is a risk factor for simulator sickness.
-Use of category III medication.
De novo PD subjects:
-History of dopaminergic medication use.
-Presence of premorbid pathology, i.e. experienced cerebral infarction or chronic depression, non-related to Parkinson’s disease.
Healthy control subjects:
-Presence of psychiatric disorders, i.e. depression or psychosis.
-History of neurological disorders, which may interfere with cognitive functioning (e.g. recent concussion, previous subarachnoid or intracerebral haemorrhage, intracranial tumours, epilepsy, ischemic strokes).
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Driving simulator performance of de novo PD patients compared to HC, using the SDLP during Swing Drive part 1.
- Secondary Outcome Measures
Name Time Method Secondary outcome measures will be other driving simulator variables (e.g. speed, percentage of lane crossing, reaction time to triggered events and number of violations) and the identification of correlates between SDLP and potential predictors, i.e. neuropsychological test scores and motor scores.